Imegen
Company

Last deal

Amount

Series A

Stage

01.03.2017

Date

3

all rounds

$854.22K

Total amount

date founded

Financing round

General

About Company
Igmo Genomica is a biomedical company that offers genetic analysis services and products.

Industry

Sector :

Subsector :

Also Known As

Instituto de Medicina Genomica

founded date

08.07.2009

founders

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

The company aims to be a global leader in human genetics by providing one of the most comprehensive portfolios in genetic analysis, collaborating with national and international companies and research teams, and investing in R&D to stay competitive. Its genetics diagnosis services use DNA and RNA analysis technologies to detect genetic diseases, making genetics accessible to individuals, families, hospitals, and other healthcare institutions to improve people's quality of life.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Eone Diagnomics Genome Center

Eone Diagnomics Genome Center

Eone Diagnomics Genome Center offers genomic analysis for genetic diseases and cancer medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Genetics

Location

Incheon, South Korea

total rounds

1
Centogene

Centogene

CENTOGENE transforms genetic data into medical decisions for rare diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Rostock, Germany

total rounds

6

total raised

$224.93M
IntegraGen

IntegraGen

IntegraGen develops molecular markers for CNS and metabolic diseases, leveraging its IP, research expertise, and sample libraries.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Évry, 91000 Évry-Courcouronnes, France

total rounds

4

total raised

$12.16M
Datar Genetics

Datar Genetics

Datar Genetics is a cutting-edge European company specializing in genetic sequencing and analysis.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Nashik, Maharashtra, India

total rounds

1
M&A Details
1

Acquired by

Qualitas Equity Partners

announced date

16.03.2017

price

$10.77M
Local Amount - EUR 10M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$854.22K

Money Raised

Their latest funding was raised on 01.03.2017. Their latest investor Realiza Business Angels. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.03.2017
1
01.11.2011
1
01.09.2009
1
$854.22K
Local Amount - EUR 600K
Realiza Business Angels

Realiza Business Angels

Realiza Business Angels is an angel group based in Valencia, Spain.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Financial Services, Venture Capital, Finance

Location

Valencia, Spain

count Of Investments

15

count Of Exists

2
Co-Investors
Investors
2
1

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Seed, Venture - Series Unknown
No
Series A
Realiza Business Angels

Realiza Business Angels

Realiza Business Angels is an angel group based in Valencia, Spain.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Financial Services, Venture Capital, Finance

Location

Valencia, Spain

count Of Investments

15

count Of Exists

2
Fides Capital

Fides Capital

Fides Capital is an investment firm that specializes in seed and early-stage technology-based companies with scalable B2B business models.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

Madrid, Spain

count Of Investments

23

count Of Exists

3
Acquisitions
1
Acquiree Name 
Date 
Price 
Acquisition Name 
Genetaq acquired by Imegen

Genetaq acquired by Imegen

acquirer

Imegen
Imegen

date

07.09.2018

type

Acquisition
Genetaq

Genetaq

GENETAQ is a laboratory specializing in human molecular genetics.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Biotechnology, Genetics, Health Care

Location

Málaga, Spain

People

Founders
1
Manuel Perez
Manuel Perez

Manuel Perez

Director and Scientific Advisory doctoral degree in Biology and Molecular Genetics after spending three years at the Laboratory of Molecular Genetics, University of Lund (Sweden). He is Professor of Genetics at the University of Valencia, where he founded the Laboratory of Molecular Genetics of Development. In his laboratory at the university, has developed more than twenty research projects funded by various national and international organizations, and three biotechnology patents that have been transferred to the biopharmaceutical industry. Among his contributions to the field of genomics, highlights its participation in three international consortia genome sequencing. It was scientific advisor to Roche in the area of DNA sequencing. For twelve years, since its founding in 1998 until April 2009, has been the promoter and founding partner of the firm Genome Systems SL, where he held the post of Scientific and Strategic Officer. Currently he is founder and Scientific Director of the company Valentia BioPharma and the Institute of Genomic Medicine, both located in the University of Valencia Science Park. Other projects include collaboration with the multinational Life Technologies, in developing applications ultrasecuenciación genomes by SOLiD technology. Among his published research, it should be noted three publications in the prestigious scientific journal Nature. Currently, his research focuses on the development of genomic tools for genetic diagnosis of hereditary diseases and biopharmaceutical research to combat rare genetic diseases.

current job

Valentia Biopharma
Valentia Biopharma

organization founded

2

Manuel Perez

Employee Profiles
5
Javier Garcia

Javier Garcia

Scientific Director

Angela Perez

Angela Perez

CEO

Carlos Ruiz

Carlos Ruiz

Technical Director

Maria Garcia

Maria Garcia

Head of Medical

Activity

Recent News
0